Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ascites: its correction by peritoneovenous shunting.

H H LeVeen, S Wapnick, C Diaz

    Current Problems in Surgery
    |February 1, 1979
    PubMed
    Summary

    Peritoneovenous shunting is an urgent treatment for refractory ascites and hepatorenal syndrome (HRS), effectively managing fluid overload and kidney dysfunction. This procedure is also beneficial for ascites from other causes, with careful patient selection mitigating risks.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Properties of Heavy Cosmic Nuclei Phosphorus, Chlorine, Argon, Potassium, and Calcium: Results from the Alpha Magnetic Spectrometer.

    Physical review letters·2026
    Same author

    Subcortical recruitment dissociates isoflurane emergence from distinct wakeful states in mice.

    bioRxiv : the preprint server for biology·2026
    Same author

    Post-endoscopy esophageal adenocarcinoma: Insights from a multicenter cohort in Colombia.

    Revista de gastroenterologia de Mexico (English)·2026
    Same author

    International Consensus Meeting on Infection: Top 10 Evidence-Backed Recommendations and Insights.

    The Journal of bone and joint surgery. American volume·2025
    Same author

    Breeding for thermotolerance in dairy cattle: Production versus fertility traits.

    Journal of dairy science·2025
    Same author

    Climate resilience differs across dairy sheep populations in Europe.

    Animal : an international journal of animal bioscience·2025

    Area of Science:

    • Gastroenterology and Hepatology
    • Nephrology
    • Surgical Interventions

    Background:

    • Refractory ascites and hepatorenal syndrome (HRS) represent a critical stage in liver disease, often indicating a poor prognosis.
    • Current management strategies for ascites can be limited, necessitating advanced interventions.
    • Peritoneovenous shunting offers a continuous reinfusion method for managing fluid overload and associated complications.

    Purpose of the Study:

    • To evaluate the efficacy and indications for peritoneovenous shunting in patients with refractory ascites and HRS.
    • To identify contraindications and patient selection criteria for the procedure.
    • To assess the utility of peritoneovenous shunting in ascites of diverse etiologies.

    Main Methods:

    • Review of clinical data and outcomes for patients undergoing peritoneovenous shunting.

    Related Experiment Videos

  • Analysis of a randomized prospective study comparing shunt therapy with other treatments.
  • Assessment of complications and patient selection based on clinical status (e.g., encephalopathy, jaundice, sepsis, cardiac disease).

    • Main Results:

    • Peritoneovenous shunting effectively corrects sodium retention, oliguria, and azotemia in patients with refractory ascites and HRS.
    • Severe encephalopathy, jaundice, or peritoneal sepsis are contraindications prior to improvement.
    • Cardiac disease does not contraindicate shunting if fluid is removed and diuretics are used; the procedure is also useful for non-cirrhotic ascites.

    Conclusions:

    • Peritoneovenous shunting is an urgent option for refractory ascites and HRS, improving renal function and fluid balance.
    • Careful patient selection is crucial, avoiding shunting in cases of severe encephalopathy, jaundice, or sepsis.
    • The study suggests considering shunting for diet-resistant massive ascites even before diuretic therapy failure.